Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: BD PosiFlush™ SP Pre-Filled Saline Syringe
Active Ingredient: Sodium chloride 0.9%
Dosage Form: Solution
New Zealand Sponsor: Becton Dickinson Limited
Manufacturer: BD Medical Surgical, Nebraska, United States of America
Product: Benadryl Mucus Relief
Active Ingredient: Guaifenesin 20mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Famar Orleans, Orleans Cedex, France
Product: Codral Relief Mucus Cough
Active Ingredient: Guaifenesin 20mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Famar Orleans, Orleans Cedex, France
Product: Gaviscon Double Strength
Active Ingredients: Potassium bicarbonate 20mg/mL
Sodium alginate 100mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare (UK) Limited, Yorkshire, United Kingdom
Product: Trexate
Active Ingredient: Methotrexate 2.5mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Goa, India
Product: Trexate
Active Ingredient: Methotrexate 10mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Goa, India
Dated this 14th day of March 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).